High Potency Active Pharmaceutical Ingredients - Future of the Global Industry by 2023 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

High Potency Active Pharmaceutical Ingredients - Future of the Global Industry by 2023

Description:

The global HPAPI market is expected to reach USD 26.84 Billion by 2023 from USD 16.49 Billion in 2017, at a CAGR 8.7%. The base year considered for the study is 2017 and the forecast period is from 2018 to 2023. – PowerPoint PPT presentation

Number of Views:17
Date added: 5 September 2018
Slides: 12
Provided by: mmvaidya

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: High Potency Active Pharmaceutical Ingredients - Future of the Global Industry by 2023


1
MarketsandMarkets Presents
High Potency Active Pharmaceutical Ingredients -
Future of the Global Industry by 2023
https//www.marketsandmarkets.com/Market-Reports/h
igh-potency-api-market-36582475.html
2
The report "High Potency APIs /HPAPI Market by
Type (Innovative, Generic), Synthesis (Synthetic,
Biotech, moAB, Vaccines, Recombinant Proteins),
Manufacturer (Captive and Merchant), Therapy
(Oncology, Glaucoma, Hormonal Imbalance) - Global
Forecasts to 2023", The global HPAPIs market is
expected to reach USD 26.84 Billion by 2023 from
USD 17.72 Billion in 2018, at a CAGR
8.7. Browse 239 market data tables 42 figures
216 pages And in-depth TOC on High Potency APIs
/HPAPI Market Download The PDF
Brochure_at_ https//www.marketsandmarkets.com/pdfdow
nload.asp?id36582475 The growth in this market
is driven by factors such as increasing demand
for oncology drugs, growing demand for
antibody-drug conjugates, increasing focus of
leading pharmaceutical companies on HPAPIs,
advancements in HPAPI manufacturing technologies,
and growing focus on precision medicine.
https//www.marketsandmarkets.com/Market-Reports/h
igh-potency-api-market-36582475.html
3
The objectives of this study are as follows.
To define, describe, and forecast the global
HPAPI market on the basis of type, type of
manufacturer, type of synthesis, therapeutic
application, and region. To provide detailed
information about factors influencing market
growth (drivers, restraints, opportunities, and
industry-specific challenges) To strategically
analyze micromarkets with respect to the
individual growth trends, prospects, and
contributions to the overall market To analyze
market opportunities for stakeholders and provide
details of the competitive landscape for key
players To forecast the size of the market
segments of North America, Europe, Asia, and the
Rest of the World (RoW) To profile key players
and comprehensively analyze their product
portfolios, market positions, and core
competencies
https//www.marketsandmarkets.com/Market-Reports/h
igh-potency-api-market-36582475.html
4
https//www.marketsandmarkets.com/Market-Reports/h
igh-potency-api-market-36582475.html
5
The innovative HPAPIs segment to dominate the
market in 2018 Based on type, the HPAPIs market
is segmented into innovative and generic HPAPIs.
In 2018, the innovative HPAPIs segment is
expected to account for the largest share of the
market. The large share can be attributed to the
increased investments of innovator companies in
RD, manufacture, marketing, and supply of
innovative HPAPIs as the revenue generated from
these molecules are considerably high. Talk to
Our Research Experts_at_ https//www.marketsandmarke
ts.com/speaktoanalyst.asp?id36582475 Based on
type of manufacturer, the captive manufacturers
segment to dominate the market in 2018
https//www.marketsandmarkets.com/Market-Reports/h
igh-potency-api-market-36582475.html
6
On the basis of type of manufacturer, the HPAPIs
market is segmented into captive HPAPI and
merchant HPAPI manufacturers. In 2018, the
captive HPAPI manufacturers segment is expected
to account for the largest share of the market.
The large share of this segment is attributed to
the preference of innovative companies to
maintain in-house manufacturing facilities for
economic benefits. The biotech HPAPIs segment is
projected to grow at the highest CAGR during the
forecast period. On the basis of type of
synthesis, the HPAPIs market is categorized into
synthetic and biotech HPAPIs. The biotech HPAPIs
segment is expected to grow at the highest CAGR
during the forecast period.
https//www.marketsandmarkets.com/Market-Reports/h
igh-potency-api-market-36582475.html
7
Advances in biotechnology, growing demand for
antibody-drug conjugates, growing demand due to
their specificity in action, their similarity
with the natural biological compounds, and
significant growth in the demand for monoclonal
antibodies are the major factors driving the
growth of this market. North America to dominate
the HPAPIs market in 2018 In 2018, North America
is expected to account for the largest share of
the market followed by Europe. Factors such
growing incidence of cancer, increasing
investments in cancer research, technological
advancements in HPAPI manufacturing, growing CMOs
market, constructive government reforms like the
Patient Protection and Affordable Care Act,
growing focus of leading pharmaceutical companies
in the HPAPIs segment, and increasing demand for
antibody-drug conjugates (ADCs) are responsible
for the large share of NA
https//www.marketsandmarkets.com/Market-Reports/h
igh-potency-api-market-36582475.html
8
The HPAPIs market is fragmented, with the
presence of several large as well as emerging
players. Prominent players in the HPAPIs market
include Pfizer (US), Novartis International AG
(Switzerland), Sanofi (France), Boehringer
Ingelheim (Germany), Bristol-Myers Squibb (US),
Teva (Israel), Eli Lilly and Company (US), Merck
(US), AbbVie (US), Mylan (US), and F. Hoffmann-La
Roche (Switzerland). Players in this market are
adopting various organic and inorganic
strategies, such as agreements, collaborations,
alliances, and partnerships mergers and
acquisitions and expansions.
https//www.marketsandmarkets.com/Market-Reports/h
igh-potency-api-market-36582475.html
9
About MarketsandMarkets MarketsandMarkets
provides quantified B2B research on 30,000 high
growth niche opportunities/threats which will
impact 70 to 80 of worldwide companies
revenues. Currently servicing 5000 customers
worldwide including 80 of global Fortune 1000
companies as clients. Almost 75,000 top officers
across eight industries worldwide approach
MarketsandMarkets for their painpoints around
revenues decisions.   Our 850 fulltime analyst
and SMEs at MarketsandMarkets are tracking
global high growth markets following the "Growth
Engagement Model GEM". The GEM aims at
proactive collaboration with the clients to
identify new opportunities, identify most
important customers, write "Attack, avoid and
defend" strategies, identify sources of
incremental revenues for both the company and its
competitors. MarketsandMarkets now coming up
with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies,
innovators, strategic players) annually in high
growth emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve.   MarketsandMarketss flagship
competitive intelligence and market research
platform, "RT" connects over 200,000 markets and
entire value chains for deeper understanding of
the unmet insights along with market sizing and
forecasts of niche markets.   
https//www.marketsandmarkets.com/Market-Reports/h
igh-potency-api-market-36582475.html
10
Contact Us
Mr. Shelly Singh MarketsandMarkets INC. 630
Dundee Road Suite 430 Northbrook, IL 60062 USA
1-888-600-6441 Email sales_at_marketsandmarkets.c
om MarketsandMarkets Bloghttp//www.marketsandma
rkets.comhttp//twitter.com/marketsmarkets http/
/www.linkedin.com/company/marketsandmarkets
11
(No Transcript)
About PowerShow.com